SUVI HYYTIAINEN: Open Payments
NPI 1962873604 · STERLING, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 47 payments from 15 companies in 2025. Trend: 2023 $393 · 2024 $1,197 · 2025 $1,662
Food & beverage: $1,662
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $242 |
| Teva Pharmaceuticals USA, Inc. | 6 | $229 |
| Neurocrine BioSciences, Inc. | 4 | $190 |
| Otsuka America Pharmaceutical, Inc. | 4 | $182 |
| Janssen Pharmaceuticals, Inc | 2 | $167 |
| Axsome Therapeutics, Inc. | 3 | $145 |
| Corium, LLC | 4 | $95 |
| Supernus Pharmaceuticals, Inc. | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Bausch Health US, LLC | 3 | $67 |
Products named: FANAPT, UZEDY, INGREZZA, Auvelity, SPRAVATO, REXULTI, Azstarys, Qelbree.
Industry payments across VA — which companies pay providers there.
